Fil d'Ariane
Documents et Média
Bayesian models for aggregate and individual patient data component network meta-analysis
Bayesian models for aggregate and individual patient data component network meta-analysis
Version 1.0 Approuvé
- Type de document
- EXTERNAL_DOCUMENT
- Extension
- png
- Taille
- 170 Ko
- Modifié
- 21/10/22 13:16 par mir mir
- Créé(e)
- 21/10/22 13:16 par mir mir
- Localisation
- PUBLIC
- Notations
-
-
Version 1.0Par mir mir, sur 21/10/22 13:16Log Pas de changement
Résumé
Abstract
Network meta-analysis can synthesize evidence from studies comparing multiple treatments for the same disease. Sometimes the treatments of a network are complex interventions, comprising several independent components in different combinations. A component network meta-analysis (CNMA) can be used to analyze such data and can in principle disentangle the individual effect of each component. However, components may interact with each other, either synergistically or antagonistically. Deciding which interactions, if any, to include in a CNMA model may be difficult, especially for large networks with many components. In this article, we present two Bayesian CNMA models that can be used to identify prominent interactions between components. Our models utilize Bayesian variable selection methods, namely the stochastic search variable selection and the Bayesian LASSO, and can benefit from the inclusion of prior information about important interactions. Moreover, we extend these models to combine data from studies providing aggregate information and studies providing individual patient data (IPD). We illustrate our models in practice using three real datasets, from studies in panic disorder, depression, and multiple myeloma. Finally, we describe methods for developing web-applications that can utilize results from an IPD-CNMA, to allow for personalized estimates of relative treatment effects given a patient's characteristics.

Le projet COMPAR-EU a été financé par le programme de recherche et d'innovation Horizon 2020 de l'Union européenne dans le cadre de la convention de subvention n° 754936.
Veuillez noter qu'il s'agit de la version bêta de la plateforme COMPAR-EU. Il comprend désormais les résultats complets concernant le diabète et, au cours de l'été 2022, les résultats concernant l'obésité, la BPCO ainsi que l'insuffisance cardiaque seront complétés. La plateforme sera également étendue et améliorée pendant les mois à venir.